Abstract LB-210: KPT-8602 is a second-generation XPO1 inhibitor with improvedin vivotolerability that demonstrates potent acute lymphoblastic leukemia activity
| Image |  |
|---|---|
| Description | |
| Author/s | |
| Publication date | July 15, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |